Cancer nanomedicine meets immunotherapy: opportunities and challenges

Cancer nanomedicines have shown promise in combination immunotherapy, thus far mostly preclinically but also already in clinical trials. Combining nanomedicines with immunotherapy aims to reinforce the cancer-immunity cycle, via potentiating key steps in the immune reaction cascade, namely antigen r...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Acta Pharmacol Sin
Prif Awduron: Sun, Qingxue, Bai, Xiangyang, Sofias, Alexandros Marios, van der Meel, Roy, Ruiz-Hernandez, Eduardo, Storm, Gert, Hennink, Wim E., De Geest, Bruno, Kiessling, Fabian, Yu, Hai-jun, Lammers, Twan, Shi, Yang
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer Singapore 2020
Pynciau:
Review Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7470866/
https://ncbi.nlm.nih.gov/pubmed/32555445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41401-020-0448-9
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg